Evidence map›Paper›PMID 31659509›Full record

ArticleEJNMMI radiopharmacy and chemistry2019

Automated preparation of clinical grade [

Mohammad B Haskali, Peter D Roselt, David Binns, Amit Hetsron, Stan Poniger, Craig A Hutton, Rodney J Hicks

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Tailored Reaction Conditions and Automated Radiolabeling of [International journal of molecular sciences · 2025
    Article
  3. Article
  4. Towards Optimal AutomatedJournal of labelled compounds & radiopharmaceuticals · 2024
    Article
  5. Good practices forEJNMMI radiopharmacy and chemistry · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad B HaskaliThe Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. mo.haskali@petermac.org.
Peter D RoseltThe Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
David BinnsThe Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Amit HetsronThe Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Stan PonigeriPHASE Technologies Pty. Ltd., Melbourne, Australia.
Craig A HuttonSchool of Chemistry, The University of Melbourne, Victoria, 3010, Australia.
Rodney J HicksThe Centre for Molecular Imaging and Translational Research Laboratory, The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Funding

Peter MacCallum Cancer Centre 1728
6 · The paper itself

Abstract

backgroundGallium-68 ([

resultsThe use of the MultiSyn module for

conclusions[

Indexed as

[68Ga]Ga-DOTA-CP04CCK-2, positron emission tomographyNeuroendocrine tumorSomatostatin receptor

Identifiers

PMID31659509
PMCPMC6707997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.